Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.
LUYE PHARMA GROUP LTD.
綠 葉 製 藥 集 團 有 限 公 司
(Incorporated in the Bermuda with limited liability)
(Stock Code: 02186)
CHANGE OF NAME OF PRINCIPAL SHARE REGISTRAR AND TRANSFER OFFICE IN BERMUDA
The board of directors (the ''Board'') of Luye Pharma Group Ltd. (the ''Company'') announces that the principal share registrar and transfer office of the Company in Bermuda has been changed from Codan Services Limited to Conyers Corporate Services (Bermuda) Limited with effect from 31 March 2017. The address of the principal share registrar and transfer office of the Company in Bermuda remains unchanged.
By order of the Board
LUYE PHARMA GROUP LTD.
Liu Dian Bo
Chairman
Hong Kong, 18 April 2017
As at the date of this announcement, the executive directors of the Company are Mr. LIU Dian Bo, Mr. YANG Rong Bing, Mr. YUAN Hui Xian and Ms. ZHU Yuan Yuan; the non-executive director of the Company is Mr. SONG Rui Lin; and the independent non-executive directors are Mr. ZHANG Hua Qiao, Professor LO Yuk Lam, Mr. LEUNG Man Kit and Mr. CHOY Sze Chung Jojo.
Luye Pharma Group Ltd. published this content on 18 April 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 28 April 2017 09:04:17 UTC.
Original documenthttp://www.luye.cn//lvye_en/uploads//2017-04/28/_1493369919_euvy4v.pdf
Public permalinkhttp://www.publicnow.com/view/71C7F7EBC66D1B863068DDA94243829D6C666103